Real-world outcomes of faricimab in treating diabetic macular edema up to two years. [PDF]
Khetan T +4 more
europepmc +1 more source
Evaluation of Spectral Domain OCT Changes Following Anti-VEGF Therapy in Diabetic Macular Edema.
Mandloi G +4 more
europepmc +1 more source
Early Switch to Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema Poorly Responding to Anti-VEGF Therapy: A Narrative Review. [PDF]
Sacconi R +8 more
europepmc +1 more source
Twelve‑Month Response and Safety of Intravitreal Dexamethasone Implant in Treatment‑Naïve and Recalcitrant Diabetic Macular Edema (TREAT-DME Study). [PDF]
Chakraborty S +3 more
europepmc +1 more source
Persistent Vision Loss of Eyes Lost to Follow-Up with Diabetic Macular Edema Receiving Intravitreal Anti-VEGF Therapy. [PDF]
Zhou C +29 more
europepmc +1 more source
Association Between Serum Vitamin D3 Levels and Diabetic Macular Edema in Patients with Type 2 Diabetes: A Retrospective Case-Control Study. [PDF]
Al-Latayfeh M +6 more
europepmc +1 more source
Changes in the macrophage-like cells following progression and treatment of diabetic macular edema. [PDF]
Sathishkumar S, Ratra D.
europepmc +1 more source
Cataract surgery and the risk of developing recurrence or progression of diabetic macular edema. [PDF]
Kim M, Park YG, Park YH.
europepmc +1 more source
Management of coexisting cataract and diabetic macular edema: a comparative study of dexamethasone implant versus anti-VEGF agents injections. [PDF]
Kelkar A +5 more
europepmc +1 more source

